Protein S Human

CHEMBL6068491 Phase 4 已批准 Protein
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

Protein S (human) is a plasma-derived vitamin K-dependent glycoprotein that functions as a non-enzymatic cofactor for activated Protein C, enhancing its anticoagulant activity by accelerating the inactivation of coagulation factors Va and VIIIa. It is used as replacement therapy in patients with hereditary Protein S deficiency presenting with thromboembolic complications.

治疗领域

作用机制

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

机制

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

常见问题

Protein S (human) is a plasma-derived vitamin K-dependent glycoprotein that functions as a non-enzymatic cofactor for activated Protein C, enhancing its anticoagulant activity by accelerating the inactivation of coagulation factors Va and VIIIa. It is used as replacement therapy in patients with hereditary Protein S deficiency presenting with thromboembolic complications.

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

Yes, Protein S Human is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL6068491. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.